@misc{10498/21827, year = {2018}, month = {3}, url = {http://hdl.handle.net/10498/21827}, abstract = {Netherlands Objectives: Invasivemold infections associated with Aspergillus species are a significant cause of mortality in immunocompromised patients. The most frequently occurring aetiological pathogens are members of the Aspergillus section Fumigati followed by members of the section Terrei. The frequency of Aspergillus terreus and related (cryptic) species in clinical specimens, as well as the percentage of azole-resistant strains remains to be studied. Methods: A global set (n = 498) of A. terreus and phenotypically related isolates was molecularly identified (beta-tubulin), tested for antifungal susceptibility against posaconazole, voriconazole, and itraconazole, and resistant phenotypes were correlated with point mutations in the cyp51A gene. Results: The majority of isolates was identified as A. terreus (86.8%), followed by A. citrinoterreus (8.4%), A. hortai (2.6%), A. alabamensis (1.6%), A. neoafricanus (0.2%), and A. floccosus (0.2%). One isolate failed to match a known Aspergillus sp., but was found most closely related to A. alabamensis. According to EUCAST clinical breakpoints azole resistance was detected in 5.4% of all tested isolates, 6.2% of A. terreus sensu stricto (s.s.) were posaconazole-resistant. Posaconazole resistance differed geographically and ranged from 0% in the Czech Republic, Greece, and Turkey to 13.7% in Germany. In contrast, azole resistance among cryptic species was rare 2 out of 66 isolates and was observed only in one A. citrinoterreus and one A. alabamensis isolate. The most affected amino acid position of the Cyp51A gene correlating with the posaconazole resistant phenotype was M217, which was found in the variation M217T and M217V. Conclusions: Aspergillus terreus was most prevalent, followed by A. citrinoterreus. Posaconazole was the most potent drug against A. terreus, but 5.4% of A. terreus sensu stricto showed resistance against this azole. In Austria, Germany, and the United Kingdom posaconazole-resistance in all A. terreus isolates was higher than 10%, resistance against voriconazole was rare}, publisher = {FRONTIERS MEDIA SA}, keywords = {cryptic species}, keywords = {Aspergillus section Terrei}, keywords = {susceptibility profiles}, keywords = {azoles}, keywords = {Cyp51A}, title = {Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?}, doi = {10.3389/fmicb.2018.00516}, author = {Zoran, Tamara and Sartori, Bettina and Sappl, Laura and Aigner, Maria and Sánchez-Reus, Ferrán and Rezusta, Antonio and Chowdhary, Anuradha and Taj-Aldeen, Saad J. and Arendrup, Maiken C. and Oliveri, Salvatore and Kontoyiannis, Dimitrios P. and Alastruey-Izquierdo, Ana and Lagrou, Katrien and Lo Cascio, Giuliana and Meis, Jacques F. and Buzina, Walter and Farina, Claudio and Drogari-Apiranthitou, Miranda and Grancini, Anna and Tortorano, Anna M. and Willinger, Birgit and Hamprecht, Axel and Johnson, Elizabeth and Klingspor, Lena and Arsic-Arsenijevic, Valentina and Cornely, Oliver A. and Meletiadis, Joseph and Prammer, Wolfgang and Tullio, Vivian and Vehreschild, Jörg-Janne and Trovato, Laura and Lewis, Russell E. and Segal, Esther and Rath, Peter-Michael and Hamal, Petr and Rodríguez Iglesias, Manuel Antonio and Roilides, Emmanuel and Arikan-Akdagli, Sevtap and Chakrabarti, Arunaloke and Colombo, Arnaldo L. and Fernández, Mariana S. and Martin Gomez, M. Teresa and Badali, Hamid and Petrikkos, Georgios and Klimko, Nikolai and Heimann, Sebastian M. and Uzun, Omrum and Roudbary, Maryam and de la Fuente, Sonia and Houbraken, Jos and Risslegger, Brigitte and Lass-Flörl, Cornelia and Lackner, Michaela}, }